| Safety profile |
 |
Category:
|
Main effects:
- Open and closed eye visuals, euphoria, change in perception of time
|
Side effects:
- Nausea, vasoconstriction (mostly when combined with other vasoconstricting substances like LSD), unusual body sensations (facial flushing, chills, goosebumps, body energy), slight increase in heart rate, difficulty focusing
|
Health risks:
- paranoia, fear, and panic, dystonia (rare), seizure (rare), death (rare)
|
Important safety remarks:
- 25I-NBOH is a very new substance, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.
- Elaborate studies on this substance have not been performed, so long term effects are UNKNOWN!
- Warning: This chemical is active in the microgram (µg) range! Please use extreme caution if working with this substance, a milligram scale and liquid measurement are VITAL! Please start with doses of 500µg or less!
|
25I-NBOH (NBOH-2CI, Cimbi-27) is a derivative of the phenethylamine derived hallucinogen 2C-I. It acts as a potent agonist for the 5HT2A receptor, with a Ki of 0.061nM at the human 5HT2A receptor, similar to the better-known compound 25I-NBOMe, making it some twelve times the potency of 2C-I itself.
It was discovered in 2006 by a team at Purdue University.
Links
Reference
